Q4 2021 Holdings
Filed 2022-02-11 | 10 holdings | $11.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc.(CRNX) | Common Stock | 22663K107 | $11.7M | 410,360 | 98.5% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $45.8K | 3,561,150 | 0.4% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $37.8K | 498,558 | 0.3% |
| Passage Bio, Inc. | Common Stock | 702712100 | $31.5K | 4,959,769 | 0.3% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $27.5K | 2,320,381 | 0.2% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $13.1K | 617,727 | 0.1% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $8.9K | 5,068,233 | 0.1% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $8.6K | 1,673,700 | 0.1% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.8K | 543,753 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $276 | 101,855 | 0.0% |